CanSense
PrivateLast Round
Crowdfunding
Dec 5, 2025
Est. Valuation
$8.32M
Total Funding Raised
$7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CanSense is a biotechnology company that develops a non-invasive blood test using AI and laser spectroscopy for the early detection of bowel cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CanSense Comparables
Compare CanSense with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dxcover | 86% | |
| Universal Diagnostics | 79% | |
| VolitionRx Limited | 77% |
CanSense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Dec 5, 2025 | ||||
| Grant | Apr 28, 2025 | ||||
| Grant | Jan 28, 2025 | ||||
| Grant | Nov 11, 2024 | ||||
| Grant | Nov 23, 2023 | ||||
Seed | Mar 8, 2023 |
CanSense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Mercia Asset Management | Seed |
| National Institute for Health and Care Research | Grant |
| Welsh Government | Grant |
| Northern Ireland Department for the Economy | Grant |
| Development Bank of Wales | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 110% MoM.
- Jul 24, 2026
Monthly visitors grew 273% MoM, reaching 366.
CanSense Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CanSense's valuation, stock price, and market status.
Is CanSense a public or private company?
CanSense is a private company.
What is the current stock price of CanSense?
CanSense is a private company with no public stock price. No recent secondary market data is available.
How much is CanSense worth (valuation)?
Valuation information for CanSense is not publicly available.
Can I buy CanSense stock?
CanSense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CanSense's last funding round?
CanSense's most recent funding round was Grant on January 28, 2025.
Who are the main investors in CanSense?
Key investors in CanSense include Development Bank of Wales.
Will CanSense IPO soon?
No public IPO plans have been announced for CanSense.
How can I track CanSense secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CanSense's secondary market activity and sign up for updates.